Prerna Mehta

Ms. Prerna Mehta

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 January 2024 in Journal of Intelligent Systems and Internet of Things
Verified
Journal Article
Closed access
PDF file
PPPrerna Prerna
Prerna Prerna
VTVibha Tiwari
Vibha Tiwari
JUJyoti Uikey
Jyoti Uikey
PMPrerna Mehta
Prerna Mehta
CRChopparapu Srinivasa Rao
Chopparapu Srinivasa Rao
KIRAN SREE POKKULURIKIRAN SREE POKKULURI
KIRAN SREE POKKULURI
Healthcare Internet of Things (IoT) initiatives that aim to integrate technology and medicine are shaking the sector to its foundations. The revolutionary potential of the proposed strategy is shown here as we investigate the far-reaching consequences of the Healthcare IoT on remote patient monitoring. The beginning sets the stage by underlining the significance of bridging the gap between technology and medicine. Our multi-pronged approach comprises Internet of Things (IoT) remote monitoring, cloud-based analysis, artificial intelligence (AI) integrated diagnostics, real-time alerts, and predictive analytics. Our study's results demonstrate that the proposed approach is superior to the status quo. The area of remote patient monitoring has profited considerably from the employment of traditional approaches, such as the fusion of data from wearable sensors, analysis in the cloud, diagnostics that utilize artificial intelligence, real-time monitoring, predictive modeling, and smart alarm systems. The suggested strategy, however, performs very well across all of the most important measures of assessment. Comparatively, the accuracy rate of the conventional wearable sensor fusion approach was only 76%, whereas our suggested method reached 89%. Our strategy was also more accurate than the standard approach (88% vs. 73%). When compared to the recall rate of 68% produced by conventional methods, our suggested strategy significantly outperformed the competition. It's a great option for hospitals and clinics since it improves diagnostic precision and speed without breaking the bank.

21 February 2024 in Journal of Biomed Research
Verified
Journal Article
Open access
PDF file
PMPrerna Mehta
Prerna Mehta
Fungal alchemy harnesses fungi's enzymatic efficiency to naturally degrade synthetic plastics. Enzymes like cutinase and lipase, secreted by Aspergillus and Penicillium, break down plastics, while lignocellulolytic enzymes and oxidant ions aid in this process. Aspergillus nidulans, Bjerkandera adusta, and Pleurotus ostreatus drive bioenergy and genetic engineering innovations for a sustainable eco-friendly approach to plastic waste management and waste valorization.

30 December 2025 in Archives of Stem Cell and Therapy
Verified
Journal Article
Open access
PMPrerna Mehta
Prerna Mehta

7 June 2025
Verified
Journal Article
Open access
PDF file
PMPrerna Mehta
Prerna Mehta
The investigation of the ever-changing field of therapeutics dives deeply into cutting-edge biotechnological techniques, with a particular emphasis on the management and treatment of disease. The amalgamation of state-of-the-art biotechnological methodologies presents unequaled prospects to transform healthcare methodologies. Gene editing technologies, targeted drug delivery systems, immunotherapies, and regenerative medicine procedures are among the range of novel approaches In order to maximize therapeutic outcomes, the research also explores the potential of precision medicine and personalized medicine, concentrating on patient-specific therapy modalities, biomarker identification, and genomic insights. Precision medicine is a paradigm change towards tailored treatments that consider the specific genetic composition of each patient, the progression of their condition, and the efficacy of their treatment or treating a broad range of illnesses, including infectious infections, chronic ailments, and genetic problems. The ethical and safe implementation of these novel medicines is emphasized by patient-centered approaches, regulatory frameworks, and ethical considerations. Insights into new developments and potential paths in biotechnology treatments are offered by this study. With cutting-edge cell-based medicines and inventive gene therapies, patients and medical professionals can now look forward to a brighter future. As a whole, this investigation shows how biotechnology can fundamentally alter how diseases are managed and treated, providing a solid basis for further study and practical applications.

14 February 2026 in Research Journal of Science and Technology
Verified
Journal Article
Closed access
PMPrerna Mehta
Prerna Mehta
The present paper looks at the significance of medicinal biotechnology for the development of therapeutic drugs obtained from plant secondary metabolites. Since plants are known to contain bioactive compounds with enormous therapeutic potentials, the paper highlights the latest molecular biological approaches employed in prospection of these bioresources. Extraction, purification, and alteration of plant metabolites are classified as core technologies along with other emerging technologies like plant cell culture, metabolic engineering, and synthetic biology that enable accurate and reproducible drug manufacture. Focus is made on the pharmacology on plant derived therapeutic agents in treating diseases, such as cancer, cardiovascular diseases, neurological diseases and infectious diseases. The paper shifting the focus towards the presence of these natural compounds in modern medicine to carry out a comparative analysis of their clinical and therapeutic significance. Ultimately, "Medicinal Biotechnology: The paper “Pharmacological Biotechnology: Synthesizing Therapeutic Drugs from Plant Secondary Metabolites” demonstrate how technological developments of the synthesis of healing molecules can lead to complex therapeutic remedies for better human health and existence.